TITLE

COMPUGEN PRESENTS DAC BLOCKERS PLATFORM/INITIAL PRODUCTS

PUB. DATE
December 2009
SOURCE
Worldwide Biotech;Dec2009, Vol. 21 Issue 12, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the presentation given by Doctor Yossef Kliger, project manager at Compugen Ltd., at the Fifth Peptide Engineering Meeting in Barcelona, Spain. The presentation focused on the DAC Blockers Platform of Compugen. Kliger also reviewed disease model data for selected product candidates such as targets belonging to the Heat Shock Protein (HSP) family. Kliger explained the importance of HSP for the pharmaceutical industry.
ACCESSION #
45545718

 

Related Articles

  • Untitled. Nelson, Nancy J. // JNCI: Journal of the National Cancer Institute;1/2/2002, Vol. 94 Issue 1, p14 

    Focuses on the effectivity of heat shock proteins and peptides for immune protection in the United States. Process on the elimination of damaged cells; Limitation of the heat shock protein vaccine; Optimism on the applicability of vaccines on humans.

  • Compugen 2nd Quarter 2012 Conference Call Scheduled for Tues, Aug 7 2012 at 10:00 AM EDT.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article offers information on a conference by Compugen Ltd. to be held at Tel Aviv, Israel on August 7, 2012 in which the 2nd quarter 2012 financial results of the company.

  • Identification of an I-Ad restricted peptide on the 65-kilodalton heat shock protein of Mycobacterium avium. Nagabhushanam, Vijaya; Purcell, Anthony W; Mannering, Stuart; Germano, Susie; Praszkier, Judyta; Cheers, Christina // Immunology & Cell Biology;Dec2002, Vol. 80 Issue 6, p574 

    Abstract The 65 kilodalton heat shock protein (Hsp65) from mycobacterial species elicits immune responses and in some cases protective immunity. Here we have used a DNA sublibrary approach to identify antigenic fragments of Mycobacterium avium Hsp65 and a synthetic peptide approach to delineate...

  • Opinion: Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nicchitta, Christopher V. // Nature Reviews Immunology;May2003, Vol. 3 Issue 5, p427 

    Early investigations into the immune surveillance of chemically-induced sarcomas led to two important concepts in tumour immunobiology: one, tumour rejection can be elicited by immune recognition of tumour antigens; and two, tumours express unique sets of antigens, which are known as...

  • A murine world without HSFs: meeting report. Christians, Elisabeth; Benjamin, Ivor J. // Cell Stress & Chaperones;Winter2005, Vol. 10 Issue 4, p265 

    The article reports on key findings from a special one-day mini-symposium entitled 'Making sense of HSF mutations in mice: Does the field need another knockout model?' held at the Salve Regina University in the U.S. in July 2005. A cross section of investigators with diverse research interests...

  • Understanding of the Hsp90 molecular chaperone reaches new heights. Vaughan, Cara K.; Neckers, Len; Piper, Peter W. // Nature Structural & Molecular Biology;Dec2010, Vol. 17 Issue 12, p1400 

    Information about the 2010 International Conference for the Hsp90 Chaperone Machine, held in Switzerland is presented. It summarizes various insights from the meeting as it covered on the topic of heat shock protein 90 (Hsp90). Regulatory phosphorylation controlling Hsp90 and the development and...

  • The Hsp90 mosaic: a picture emerges. Mayer, Matthias P.; Prodromou, Chrisostomos; Frydman, Judith // Nature Structural & Molecular Biology;Jan2009, Vol. 16 Issue 1, p2 

    Information about the topics discussed at the 4th International Conference on the Hsp90 Chaperone Machine in Seeon, Germany is presented. The conference talked about the mechanistic, biochemical and structural aspects of Hsp90 proteins, its in vivo functions and the development of new Hsp90...

  • Compugen to Present at the BIO CEO & Investor Conference 2012 BIO CEO & Investor Conference 2012.  // Biomedical Market Newsletter;2/7/2012, Vol. 21, p1 

    The article offers information on a presentation from Compugen Ltd. in the BIO CEO & Investor Conference 2012 to be held in New York City on February 13, 2012.

  • Identification of the pentapeptide constituting a dominant epitope common to all eukaryotic heat shock protein 90 molecular chaperones. Kishimoto, Jun; Fukuma, Yutaka; Mizuno, Akio; Nemoto, Takayuki K. // Cell Stress & Chaperones;Winter2005, Vol. 10 Issue 4, p296 

    We previously reported that, in human heat shock protein (Hsp) 90 (hHsp90), there are 4 highly immunogenic sites, designated sites la, Ib, Ic, and II. This study was performed to further characterize their epitopes and to identify the epitope that is potentially common to all members of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics